OQS
SPRY icon

Occudo Quantitative Strategies’s ARS Pharmaceuticals SPRY Stock Holding History

Occudo Quantitative Strategies’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,057
Closed -$80K – 1338
2022
Q3 		$80K Sell
15,057
-11,965
-44% -$59K 0.01% 1053
2022
Q2 		$115K Sell
27,022
-9,309
-26% -$32.5K 0.01% 1004
2022
Q1 		$128K Sell
36,331
-21,973
-38% -$95.7K 0.01% 999
2021
Q4 		$388K Buy
58,304
+41,539
+248% +$338K 0.03% 694
2021
Q3 		$167K Buy
+16,765
New +$413K 0.02% 883

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Occudo Quantitative Strategies's SPRY Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of ARS Pharmaceuticals (SPRY) in Q4 2022, closing a stake of 15,057 shares — an estimated $80K sold.

Occudo Quantitative Strategies first reported a position in SPRY in Q3 2021 and held it in 5 quarters. The position peaked at $388K in Q4 2021. 73 funds tracked by Wall St. Rank hold SPRY as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining ARS Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 15,057 ARS Pharmaceuticals shares in Q4 2022, an estimated $80K.
  • Occudo Quantitative Strategies first reported a position in ARS Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • Occudo Quantitative Strategies's ARS Pharmaceuticals position peaked at $388K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.